199 related articles for article (PubMed ID: 4262051)
1. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
Loubathières A; Mariani MM; Ribes G; Chapal J
C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
[No Abstract] [Full Text] [Related]
2. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
3. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
Loubatières A
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
[No Abstract] [Full Text] [Related]
4. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
5. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
Loubatières A; Mariani MM; Chapal J
C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
[No Abstract] [Full Text] [Related]
6. [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Chapal J
Diabetologia; 1969 Feb; 5(1):1-10. PubMed ID: 4907149
[No Abstract] [Full Text] [Related]
7. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
8. [Hypoglycemic sulfonamides].
Loubatières AL
Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
[No Abstract] [Full Text] [Related]
9. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
Mariani MM
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
[No Abstract] [Full Text] [Related]
10. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
11. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
Kajinuma H; Kuzuya TT; Ide T
Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
[No Abstract] [Full Text] [Related]
12. Zinc and insulin content in pancreatic islets of rats after administration of hypoglycemic sulfonamides.
Lazaris YA; Kuts LG; Bavel'skii ZE
Bull Exp Biol Med; 1974 Dec; 77(6):647-9. PubMed ID: 4216382
[No Abstract] [Full Text] [Related]
13. [Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
Klin Wochenschr; 1971 Jul; 49(13):769-70. PubMed ID: 4935073
[No Abstract] [Full Text] [Related]
14. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
15. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
16. [Ultrastructural events associated with the action of tolbutamide and glybenclamide on pancreatic B-cells in vivo and in vitro].
Orci L; Stauffacher W; Renold AE; Beaven D; Lambert A; Rouiller C
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():271-374. PubMed ID: 4906021
[No Abstract] [Full Text] [Related]
17. [Stimulation of insulin secretion in vitro by a new, highly-active antidiabetic].
Schwarz H; Ammon J; Yeboah JE; Hildebrandt HE; Pfeiffer EF
Diabetologia; 1968 Jan; 4(1):10-5. PubMed ID: 4907146
[No Abstract] [Full Text] [Related]
18. The pharmacology and metabolism of oral antidiabetic drugs.
Bänder A
Aust N Z J Med; 1971 Aug; 1():Suppl 2:22-30. PubMed ID: 5005129
[No Abstract] [Full Text] [Related]
19. [Normal histology of the beta-cells during insulin secretion].
Bänder A
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():417-35. PubMed ID: 4907224
[No Abstract] [Full Text] [Related]
20. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
Pfeiffer EF
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
